Taken together, the present study aimed to elucidate the molecular mechanisms through which AQ modulates Aβ and tau aggregation and disassembly, and to evaluate the therapeutic potential of AQ as a dual-target modulator for AD. The gene discussed is MAPT; the disease is Alzheimer disease.